Private Capital Group’s Genmab GMAB Stock Holding History

Private Capital Group’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$87K	Buy	2,677 +331	+14%	+$10.7K	0.07%	293
2022 Q1	$85K	Buy	2,346 +11	+0.5%	+$378	0.02%	440
2021 Q4	$92K	Sell	2,335 -22	-0.9%	-$917	0.02%	457
2021 Q3	$103K	Buy	2,357 +12	+0.5%	+$539	0.02%	424
2021 Q2	$96K	Sell	2,345 -711	-23%	-$27.4K	0.02%	426
2021 Q1	$100K	Sell	3,056 -768	-20%	-$28.9K	0.02%	389
2020 Q4	$156K	Buy	3,824 +18	+0.5%	+$673	0.03%	364
2020 Q3	$139K	Sell	3,806 -29	-0.8%	-$1.05K	0.03%	361
2020 Q2	$130K	Sell	3,835 -299	-7%	-$8.15K	0.03%	372
2020 Q1	$88K	Buy	4,134 +477	+13%	+$10.6K	0.02%	436
2019 Q4	$81K	Buy	3,657 +13	+0.4%	+$284	0.02%	514
2019 Q3	$74K	Buy	+3,644	New	+$71.8K	0.01%	600

Other funds holding GMAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Private Capital Group's GMAB Position: Q2 2022 in Review

Private Capital Group increased its Genmab (GMAB) stake by 14% in Q2 2022, buying an estimated $10.7K and bringing the position to 2,677 shares worth $87K. The position accounts for 0.07% of the portfolio, ranked #293.

Private Capital Group first reported a position in GMAB in Q3 2019 and has held it in 12 quarters since. The position peaked at $156K in Q4 2020. 181 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

Private Capital Group held 2,677 shares of Genmab worth $87K as of Q2 2022.
Private Capital Group bought 331 Genmab shares in Q2 2022, an estimated $10.7K.
Genmab made up 0.07% of Private Capital Group's portfolio in Q2 2022, its #293 holding.
Private Capital Group first reported a position in Genmab in Q3 2019 and has held it in 12 quarters since.
Private Capital Group's Genmab position peaked at $156K in Q4 2020.
181 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.